BACKGROUND AND PURPOSE: Ticagrelor is a novel P2Y12 antagonist, and little is known
about its efficacy and safety in the endovascular treatment of aneurysms. This study …

Background and purpose Antiplatelet therapy (APT) is a key element limiting the risk of
thromboembolic events (TEE) in neuroendovascular procedures, including aneurysm …

Purpose Standard dual antiplatelet therapy (DAPT) for complex aneurysms treated with flow
diversion and flow disruption is acetylsalicylic acid (ASA) plus clopidogrel. However …

BACKGROUND Dual antiplatelet therapy (DAPT) associating aspirin+ clopidogrel is
commonly utilized in neurovascular interventions despite unpredictable clopidogrel efficacy …

Introduction Thromboembolic events represent the most frequent complications of
endovascular treatment of unruptured intracranial aneurysm using stent-assisted coilling or …

BACKGROUND: Clopidogrel is routinely used to decrease ischemic complications during
neurointerventional procedures. However, the efficacy may be limited by antiplatelet …

Background Thromboembolic complications are the main problem in stent-assisted coil
embolization of unruptured intracranial aneurysms. The combination of aspirin and …

The use of periprocedural dual antiplatelet therapy (DAPT) has significantly evolved along
with innovations in the endovascular management of intracranial aneurysms. Historically …

Abstract Background and Purpose Cangrelor is a P2Y12 inhibitor that presents the
advantage of having a short half-life. Its use may be helpful in the management of …

Object The optimal antiplatelet medication protocol for prevention of thrombotic
complications after stent-assisted coil embolization of cerebral aneurysms is unclear. Early …